1. Alexander Rudolf Cools (1942–2013)

   • Bart A. Ellenbroek
   • Judith Homberg
   • Gerard Martens

   Obituary 26 April 2014 Pages: 2219 - 2222

   

2. A critical analysis of alcohol hangover research methodology for surveys or studies of effects on cognition

   • Richard Stephens
   • James A. Grange
   • Lauren Owen

   Review 16 March 2014 Pages: 2223 - 2236

3. Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies

   • Josh Lister
   • José N. Nobrega
   • Gary Remington

   Review 22 April 2014 Pages: 2237 - 2249

   

4. The link between dopamine function and apathy in cannabis users: an [¹⁸F]-DOPA PET imaging study

   • Michael A. P. Bloomfield
   • Celia J. A. Morgan
   • Oliver D. Howes

   Original Investigation 03 April 2014 Pages: 2251 - 2259

   

5. The effects of nicotine exposure during Pavlovian conditioning in rats on several measures of incentive motivation for a conditioned stimulus paired with water

   • Elizabeth Glenn Guy
   • Paul J Fletcher

   Original Investigation 07 December 2013 Pages: 2261 - 2271

   

6. Alcohol-induced risk taking on the BART mediates alcohol priming

   • Abigail K. Rose
   • Andrew Jones
   • Paul Christiansen

   Original Investigation Open access 13 December 2013 Pages: 2273 - 2280

   

7. Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects

   • Andrew H. Kemp
   • Tim Outhred
   • Gin S. Malhi

   Original Investigation 15 December 2013 Pages: 2281 - 2290

   

8. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test

   • Kenichi Fukumoto
   • Michihiko Iijima
   • Shigeyuki Chaki

   Original Investigation 09 January 2014 Pages: 2291 - 2298

   

9. Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study

   • Robert Risinger
   • Zubin Bhagwagar
   • Wendy Hayes

   Original Investigation 15 December 2013 Pages: 2299 - 2310

   

10. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats

    • Gordon Winocur
    • J. Martin Wojtowicz
    • Ian F. Tannock

    Original Investigation 17 December 2013 Pages: 2311 - 2320

    

11. Effect of mazindol on extracellular dopamine concentration in human brain measured by PET

    • Takeshi Sakayori
    • Amane Tateno
    • Yoshiro Okubo

    Original Investigation 08 January 2014 Pages: 2321 - 2325

    

12. Dexamphetamine effects on prepulse inhibition (PPI) and startle in healthy volunteers

    • Kate Chitty
    • Matthew A. Albrecht
    • Mathew T. Martin-Iverson

    Original Investigation 18 December 2013 Pages: 2327 - 2337

    

13. Drugs of abuse as memory modulators: a study of cocaine in rats

    • Nabeel Rkieh
    • Jacob M. Cloke
    • Francesco Leri

    Original Investigation 13 December 2013 Pages: 2339 - 2348

    

14. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat

    • Jason J. Paris
    • Harminder D. Singh
    • Jay P. McLaughlin

    Original Investigation 19 December 2013 Pages: 2349 - 2360

    

15. DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine

    • Barbara Gelao
    • Leonardo Fazio
    • Alessandro Bertolino

    Original Investigation 15 January 2014 Pages: 2361 - 2370

    

16. It’s timely and time for the change: comments on Peck and Ranaldi

    • Joseph R. Troisi II

    Commentary 30 April 2014 Pages: 2371 - 2373